Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nova Mentis Life Science Corp C.NOVA

Alternate Symbol(s):  NMLSF

Healthcare Biotechnology
Nova Mentis Life Science Corp is a Canadian-based biotechnology company. It is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova uses psilocybin in the treatment of Fragile X Syndrome (FXS).

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:NOVA)

Fundamentals Snapshot (CSE:NOVA)

Current News (CSE:NOVA)

Nova Mentis (CSE:NOVA) enters mRNA AI diagnostics business

Jon Brown April 26, 2023

Nova Mentis to Enter mRNA AI Diagnostics Business

Newsfile April 26, 2023

Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial

Newsfile April 18, 2023

Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial

Newsfile April 11, 2023

Nova Mentis Provides Corporate Update and 2023 Outlook

Newsfile April 5, 2023

Autism rates are increasing in children, we need this next-level therapeutic solution

Jon Brown March 29, 2023

Novel Therapeutic Solutions are Needed as Autism Rates Increase

Newsfile March 29, 2023

Nova Mentis (CSE:NOVA) approved to begin psilocybin clinical trial

Jon Brown February 14, 2023

Nova Mentis Granted Health Canada Section 56 Exemption to Begin Psilocybin Clinical Trial

Newsfile February 14, 2023
View More News ››

Opinion & Analysis (CSE:NOVA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:NOVA)

Pump and Dump scheme

Look at Agraflora how Derek Ivany screwed its shareholders 
EnoughBull - January 30, 2023

NOVA ...... When's the Reverse Split ?

JMHO
Iseneschal - December 22, 2022

NOVA ...Halted

Trevi Fountain laced with psilocybin ....Roman crowd go wild !!!
Iseneschal - December 22, 2022

autism help

https://hellomd.ca/articles/psilocybin-may-be-the-answer-to-autism-and-a-healthy-microbiome-an-interview-with-scientist-and-researcher...
duginthemud - December 13, 2022

then...

https://www.novamentis.ca/advisory.html  and https://www.prnewswire.com/news-releases/immunologist-dr-marvin-s-hausman-md-named...
duginthemud - December 13, 2022

next

https://www.michaeljfox.org/researcher/marvin-s-hausman-md dug
duginthemud - December 13, 2022
View more Bullboard ››

Ion Energy

Ion Energy

Ion Energy Ltd is engaged in the business of exploration and development of lithium. The company is focused on the Baavhai ...
View More »